Cite
HARVARD Citation
Battipaglia, G. et al. (2017). Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia. Cancer. 123 (15), pp. 2867-2874. [Online].